The Hadley 1989 publication in Life Sciences established Melanotan II as the benchmark melanocortin agonist against which all subsequent synthetic analogs have been compared, and its design principles directly informed the development of PT-141, setmelanotide, and other clinically investigated melanocortin peptides
In another case, a 39-year-old man who had injected 6 mg of melanotan II subcutaneously presented to the hospital two hours after injection with tachycardia, diffuse body aches, a sensation of anxiety, and sweating
May improve sleep quality by regulating circadian rhythms, reducing 3AM wake-ups, supporting better cortisol management and daytime cognitive function
Find out more about how the FDA supports and regulates the sale of supplements
At Revital Trichology, we believe theres no one-size-fits-all approach to hair restoration